IN RE: PHILIP MORRIS INTERNATIONAL INC. SECURITIES LITIGATION

Track this case

Case Number:

1:18-cv-08049

Court:

New York Southern

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Ronnie Abrams

Firms

Companies

Sectors & Industries:

  1. January 02, 2024

    2nd Circ. Stubs Out Philip Morris E-Cig Investor Suit

    The Second Circuit has denied a bid from Philip Morris International investors to revive their suit over e-cigarette sales, finding in an opinion that answered questions of first impression that a lower court was right to toss a proposed class action alleging the tobacco giant lied about sales and regulation efforts for its IQOS electronic device.

  2. September 21, 2020

    Philip Morris Investors Can't Revive Suit Over E-Cig Sales

    A New York federal judge on Monday shot down a request by Philip Morris International investors who had asked the court to reconsider its decision to toss a proposed class action that alleged the company lied about sales and regulation efforts for its flagship electronic cigarette.

  3. February 04, 2020

    Philip Morris Escapes Shareholder Suit Over E-Cig Sales

    A New York federal judge on Tuesday tossed a proposed class action that alleged Philip Morris International lied about sales and regulation efforts for its flagship electronic cigarette, finding that investors hadn't shown those statements were false and misleading.

  4. September 11, 2019

    Investors Say Suit Over Philip Morris E-Cig Sales Must Go On

    Investors in Philip Morris International have told a New York federal judge they've more than adequately pled claims in their proposed class action that the company lied about sales and regulation efforts for its flagship electronic cigarette.

  5. July 15, 2019

    Philip Morris Looks To Stub Out Suit Over E-Cig Sales, Studies

    Philip Morris International asked a New York federal judge to dismiss claims that it misled investors about the sales of its flagship electronic cigarette and the device's likelihood of getting regulatory approval to be sold in the U.S.